The global veterinary biomarkers market size accounted for USD 1.24 billion in 2025 and is forecasted to hit around USD 3.73 billion by 2034, representing a CAGR of 13.00% from 2025 to 2034. The North America market size was estimated at USD 451.00 million in 2024 and is expanding at a CAGR of 13.02% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Veterinary Biomarkers Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Veterinary Biomarkers Market Revenue and Volume Forecast, by Animal Type
8.1.1. Companion Animals
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Production Animals
8.1.2.1. Market Revenue and Volume Forecast
9.1. Veterinary Biomarkers Market Revenue and Volume Forecast, by Product Type
9.1.1. Biomarkers, Kits & Reagents
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Biomarker Readers
9.1.2.1. Market Revenue and Volume Forecast
10.1. Veterinary Biomarkers Market Revenue and Volume Forecast, by Application
10.1.1. Disease Diagnostics
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Preclinical Research
10.1.2.1. Market Revenue and Volume Forecast
10.1.3. Others
10.1.3.1. Market Revenue and Volume Forecast
11.1. Veterinary Biomarkers Market Revenue and Volume Forecast, by Disease Type
11.1.1. Inflammatory & Infectious Diseases
11.1.1.1. Market Revenue and Volume Forecast
11.1.2. Cardiovascular Diseases
11.1.2.1. Market Revenue and Volume Forecast
11.1.3. Skeletal Muscle Diseases
11.1.3.1. Market Revenue and Volume Forecast
11.1.4. Tumor
11.1.4.1. Market Revenue and Volume Forecast
11.1.5. Others
11.1.5.1. Market Revenue and Volume Forecast
12.1. North America
12.1.1. Market Revenue and Volume Forecast, by Animal Type
12.1.2. Market Revenue and Volume Forecast, by Product Type
12.1.3. Market Revenue and Volume Forecast, by Application
12.1.4. Market Revenue and Volume Forecast, by Disease Type
12.1.5. U.S.
12.1.5.1. Market Revenue and Volume Forecast, by Animal Type
12.1.5.2. Market Revenue and Volume Forecast, by Product Type
12.1.5.3. Market Revenue and Volume Forecast, by Application
12.1.5.4. Market Revenue and Volume Forecast, by Disease Type
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Volume Forecast, by Animal Type
12.1.6.2. Market Revenue and Volume Forecast, by Product Type
12.1.6.3. Market Revenue and Volume Forecast, by Application
12.1.6.4. Market Revenue and Volume Forecast, by Disease Type
12.2. Europe
12.2.1. Market Revenue and Volume Forecast, by Animal Type
12.2.2. Market Revenue and Volume Forecast, by Product Type
12.2.3. Market Revenue and Volume Forecast, by Application
12.2.4. Market Revenue and Volume Forecast, by Disease Type
12.2.5. UK
12.2.5.1. Market Revenue and Volume Forecast, by Animal Type
12.2.5.2. Market Revenue and Volume Forecast, by Product Type
12.2.5.3. Market Revenue and Volume Forecast, by Application
12.2.5.4. Market Revenue and Volume Forecast, by Disease Type
12.2.6. Germany
12.2.6.1. Market Revenue and Volume Forecast, by Animal Type
12.2.6.2. Market Revenue and Volume Forecast, by Product Type
12.2.6.3. Market Revenue and Volume Forecast, by Application
12.2.6.4. Market Revenue and Volume Forecast, by Disease Type
12.2.7. France
12.2.7.1. Market Revenue and Volume Forecast, by Animal Type
12.2.7.2. Market Revenue and Volume Forecast, by Product Type
12.2.7.3. Market Revenue and Volume Forecast, by Application
12.2.7.4. Market Revenue and Volume Forecast, by Disease Type
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Volume Forecast, by Animal Type
12.2.8.2. Market Revenue and Volume Forecast, by Product Type
12.2.8.3. Market Revenue and Volume Forecast, by Application
12.2.8.4. Market Revenue and Volume Forecast, by Disease Type
12.3. APAC
12.3.1. Market Revenue and Volume Forecast, by Animal Type
12.3.2. Market Revenue and Volume Forecast, by Product Type
12.3.3. Market Revenue and Volume Forecast, by Application
12.3.4. Market Revenue and Volume Forecast, by Disease Type
12.3.5. India
12.3.5.1. Market Revenue and Volume Forecast, by Animal Type
12.3.5.2. Market Revenue and Volume Forecast, by Product Type
12.3.5.3. Market Revenue and Volume Forecast, by Application
12.3.5.4. Market Revenue and Volume Forecast, by Disease Type
12.3.6. China
12.3.6.1. Market Revenue and Volume Forecast, by Animal Type
12.3.6.2. Market Revenue and Volume Forecast, by Product Type
12.3.6.3. Market Revenue and Volume Forecast, by Application
12.3.6.4. Market Revenue and Volume Forecast, by Disease Type
12.3.7. Japan
12.3.7.1. Market Revenue and Volume Forecast, by Animal Type
12.3.7.2. Market Revenue and Volume Forecast, by Product Type
12.3.7.3. Market Revenue and Volume Forecast, by Application
12.3.7.4. Market Revenue and Volume Forecast, by Disease Type
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Volume Forecast, by Animal Type
12.3.8.2. Market Revenue and Volume Forecast, by Product Type
12.3.8.3. Market Revenue and Volume Forecast, by Application
12.3.8.4. Market Revenue and Volume Forecast, by Disease Type
12.4. MEA
12.4.1. Market Revenue and Volume Forecast, by Animal Type
12.4.2. Market Revenue and Volume Forecast, by Product Type
12.4.3. Market Revenue and Volume Forecast, by Application
12.4.4. Market Revenue and Volume Forecast, by Disease Type
12.4.5. GCC
12.4.5.1. Market Revenue and Volume Forecast, by Animal Type
12.4.5.2. Market Revenue and Volume Forecast, by Product Type
12.4.5.3. Market Revenue and Volume Forecast, by Application
12.4.5.4. Market Revenue and Volume Forecast, by Disease Type
12.4.6. North Africa
12.4.6.1. Market Revenue and Volume Forecast, by Animal Type
12.4.6.2. Market Revenue and Volume Forecast, by Product Type
12.4.6.3. Market Revenue and Volume Forecast, by Application
12.4.6.4. Market Revenue and Volume Forecast, by Disease Type
12.4.7. South Africa
12.4.7.1. Market Revenue and Volume Forecast, by Animal Type
12.4.7.2. Market Revenue and Volume Forecast, by Product Type
12.4.7.3. Market Revenue and Volume Forecast, by Application
12.4.7.4. Market Revenue and Volume Forecast, by Disease Type
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Volume Forecast, by Animal Type
12.4.8.2. Market Revenue and Volume Forecast, by Product Type
12.4.8.3. Market Revenue and Volume Forecast, by Application
12.4.8.4. Market Revenue and Volume Forecast, by Disease Type
12.5. Latin America
12.5.1. Market Revenue and Volume Forecast, by Animal Type
12.5.2. Market Revenue and Volume Forecast, by Product Type
12.5.3. Market Revenue and Volume Forecast, by Application
12.5.4. Market Revenue and Volume Forecast, by Disease Type
12.5.5. Brazil
12.5.5.1. Market Revenue and Volume Forecast, by Animal Type
12.5.5.2. Market Revenue and Volume Forecast, by Product Type
12.5.5.3. Market Revenue and Volume Forecast, by Application
12.5.5.4. Market Revenue and Volume Forecast, by Disease Type
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Volume Forecast, by Animal Type
12.5.6.2. Market Revenue and Volume Forecast, by Product Type
12.5.6.3. Market Revenue and Volume Forecast, by Application
12.5.6.4. Market Revenue and Volume Forecast, by Disease Type
13.1. Zoetis
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Virbac
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Life Diagnostics
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. ACUVET BIOTECH
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Merck & Co., Inc.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. IDEXX Laboratories, Inc
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. MI: RNA Diagnostics Ltd.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Mercodia AB
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Antech Diagnostics, Inc.
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Avacta Animal Health Limited
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample